SEC Filings
ClearPoint Neuro's Note Interest Goes All-Cash As Revenue Payments To Oberland Affiliate Loom
The device maker's first note stopped paying half its interest in kind in September, and nine-month interest expense reached $4.2 million.
CLPT
ClearPoint Neuro (CLPT) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
ClearPoint Neuro CEO Sees Possible Huntington's Gene Therapy Approval By Mid-To-Late 2027
CEO Joe Burnett said an FDA acceptance decision on partner uniQure's application could come in about a month, and 2027 growth stays near mid-teens.
Earnings
ClearPoint Neuro Taps Its Stock Program For $22 Million, Its First Use, To Fund Robotics And Ultrasound Together
The company ended the third quarter with $46.2 million in cash, and its CFO says burn should fall gradually over four to six quarters.
Earnings
ClearPoint Neuro Revenue Jumps 36% To $12.1 Million On IRRAflow, But Net Loss Widens To $7.5 Million
The brain-surgery device maker now estimates 2026 revenue of $48.0 million to $50.0 million and ended September with $46.2 million in cash.